Literature DB >> 15736029

Epidemiology of nasopharyngeal carriage of Neisseria meningitidis in healthy Dutch children.

D Bogaert1, P W M Hermans, H Boelens, M Sluijter, A Luijendijk, H C Rumke, S Koppen, A van Belkum, R de Groot, H A Verbrugh.   

Abstract

We investigated the prevalence and determinants of nasopharyngeal carriage of Neisseria meningitidis in 3200 healthy children aged 1-19 years. The incidence of meningococcal carriage was, on average, 1.5%. Peak incidences were seen at age 1 year and after age 15 years. The independent determinants of meningococcal carriage included age, regular visits to youth clubs (odds ratio [OR], 2.2) and discotheques (OR, 4.3), and pneumococcal carriage (OR, 4.1).

Entities:  

Mesh：

Year:  2005        PMID： 15736029     DOI： 10.1086/428351

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  15 in total

Review 1.  Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis.

Authors:  David S Stephens
Journal:  Vaccine       Date:  2009-05-23       Impact factor: 3.641

2.  Survival of meningococci outside of the host: implications for acquisition.

Authors:  C L Swain; D R Martin
Journal:  Epidemiol Infect       Date:  2006-07-03       Impact factor: 2.451

3.  Epidemiological analysis on two decades of hospitalisations for meningitis in the United States.

Authors:  P Pellegrino; C Carnovale; V Perrone; D Salvati; M Gentili; T Brusadelli; S Antoniazzi; M Pozzi; S Radice; E Clementi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-23       Impact factor: 3.267

Review 4.  Nasopharyngeal Bacterial Carriage in the Conjugate Vaccine Era with a Focus on Pneumococci.

Authors:  V T Devine; J M Jefferies; S C Clarke; S N Faust
Journal:  J Immunol Res       Date:  2015-08-16       Impact factor: 4.818

5.  The relationship between prior antimicrobial prescription and meningitis: a case-control study.

Authors:  David Armstrong; Mark Ashworth; Alex Dregan; Patrick White
Journal:  Br J Gen Pract       Date:  2016-03-10       Impact factor: 5.386

6.  Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada.

Authors:  Thomas E Delea; Derek Weycker; Mark Atwood; Dion Neame; Fabián P Alvarez; Evelyn Forget; Joanne M Langley; Ayman Chit
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

7.  Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development.

Authors:  Carina Brehony; Caroline L Trotter; Mary E Ramsay; Manosree Chandra; Keith A Jolley; Arie van der Ende; Françoise Carion; Lene Berthelsen; Steen Hoffmann; Hjördís Harðardóttir; Julio A Vazquez; Karen Murphy; Maija Toropainen; Manuela Caniça; Eugenia Ferreira; Mathew Diggle; Giles F Edwards; Muhamed-Kheir Taha; Paola Stefanelli; Paula Kriz; Steve J Gray; Andrew J Fox; Susanne Jacobsson; Heike Claus; Ulrich Vogel; Georgina Tzanakaki; Sigrid Heuberger; Dominique A Caugant; Matthias Frosch; Martin C J Maiden
Journal:  Clin Vaccine Immunol       Date:  2014-04-02

8.  Routine vaccination against MenB: considerations for implementation.

Authors:  Patricia Kaaijk; Arie van der Ende; Willem Luytjes
Journal:  Hum Vaccin Immunother       Date:  2013-10-18       Impact factor: 3.452

9.  Nasal carriage rate and antibiotic susceptibility pattern of Neisseria meningitidis in healthy Ethiopian children and adolescents: A cross-sectional study.

Authors:  Tinsae Alemayehu; Amha Mekasha; Tamrat Abebe
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

10.  Exploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement.

Authors:  Cosmina Hogea; Thierry Van Effelterre; Andrew Vyse
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.